Callan Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$956K Buy
2,931
+1,913
+188% +$624K 0.03% 416
2025
Q1
$275K Sell
1,018
-24
-2% -$6.48K 0.02% 443
2024
Q4
$245K Buy
+1,042
New +$245K 0.02% 549